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Abstract 8 
The use of nanodevices for biomedical applications has recently been object of 9 
study by researchers. Novel prospectives can be envisaged in the field of nano-10 
medicine, also supported by innovative nanodevices with specific properties.  11 
In this chapter, we present the electromagnetic properties of different metal na-12 
noparticles (i.e., nanocube, nanocylinder, nanorod, bow-tie, biconical nanoparti-13 
cle, etc.), opportunely functionalized for sensing applications, as well as drugged 14 
with medicament to be released to specific locations, for innovative therapeutic 15 
treatments. After modeling the design of such nanoparticles, we investigate the 16 
channel model adopted in electromagnetic nanonetworks. Basically, we focus on 17 
the nanoparticle transmission, diffusion and reception processes, both for extra- 18 
and in-vivo applications i.e., for the detection of target cells in a biological tissue 19 
sample, and for drug delivery via nanoparticle adsorption, respectively. Numerical 20 
results obtained through full-wave simulations have shown the effectiveness of 21 
electromagnetic nanoparticles for specific biomedical applications (e.g., DNA al-22 
teration detection). Finally, we highlight that in this chapter the electromagnetic 23 
properties that are described are used for sensing and drug delivery, and not for 24 
communication among nanoparticles. 25 
Introduction 26 
The concept of nanomedicine arises from the visionary idea that miniaturized 27 
devices at nanoscale level (i.e., nanodevices or nanorobots) could be designed, 28 
manufactured, and introduced into the human body, for therapeutic aims (e.g., cel-29 
lular repairs at the molecular level) [1]. The possibility of applying nanotechnolo-30 
gy to medicine has been object under study for the last decades, and it represents a 31 
2  
new approach based on the comprehension and deep knowledge of the properties 1 
of the matter at the nanoscale level [2].  2 
The intrinsic behavior and characteristics of nanodevices distinguish them from 3 
traditional devices working at the macroscale level, and particular features at the 4 
nanoscale level should be addressed [3]. Indeed, the properties of the matter dras-5 
tically change, making it necessary a synergy among several different disciplines, 6 
in order to define novel communications techniques and design efficient 7 
nanodevices [4].  8 
Generally, nanodevices represent the most basic functional unit with passive 9 
features, which allow performing very easy tasks, like sensing or actuation. A set 10 
of nanodevices, sharing the same medium (e.g., the biological tissue or the blood 11 
flow) and performing multiple tasks, form a nanonetwork [5]. Nanonetworks al-12 
low to expand the number and range of applications envisioned for single 13 
nanodevices, since collaborative tasks can be done by different nanodevices. 14 
Nowadays, applications are foreseen in four main fields, namely (i) biomedical, 15 
(ii) environmental, (iii) industrial and consumer goods, and (iv) military and de-16 
fense [3, 6]. 17 
Communication and signal transmission techniques to be utilized/used in 18 
nanonetworks are one of the most challenging topics, due to the limited computa-19 
tion skills of single nanodevices. Classical communication and network paradigms 20 
cannot be directly utilized in nanonetworks, since the poor capabilities of 21 
nanodevices pose novel challenges, establish new requirements and show novel 22 
properties that need to be opportunely addressed. As an instance, current encoding 23 
and decoding techniques are not feasible due to very limited processing capability 24 
of nanodevices, as well as traditional transceiver circuitries cannot be mounted in-25 
to them due to the limitation of the nanoscale. Also novel mobility models should 26 
be addressed accordingly to this particular field, due to specific physical rules in 27 
this regime [7].  28 
The biomedical field is one of the most challenging area of application of 29 
nanonetworks, as well as the most intriguing due to a variety of biomedical sce-30 
narios. Indeed, in the biomedical field, nanonetworks are expected to provide a 31 
perfect interface to interact with single molecules, proteins, DNA sequences and 32 
the major components of cells. Both in-vivo and extra-vivo applications of bio-33 
compatible nanodevices are largely investigated. As an instance, the use of na-34 
nosensors to detect chemical compounds in concentrations, or the presence of dif-35 
ferent infectious agents, such as virus or bacteria is an objective of several 36 
research studies [8, 9]. 37 
In the biomedical field, we highlight three main applications i.e., (i) health 38 
monitoring systems, (ii) Drug Delivery Systems (DDS), and (iii) bio-hybrid im-39 
plants. In health monitoring systems, the use of nanosensors allows detecting and 40 
monitoring different levels of molecule concentration in the blood (e.g., sodium, 41 
glucose and other ions), as well as the presence of infectious intra-body agents. 42 
The DDS use nanoactuators capable of releasing nanoparticles, drugs or biomole-43 
cules in specific locations of the body; this means that drug molecules are released 44 
3 
locally and are adsorbed only by the diseased cellular membranes, so that patients 1 
benefit from a less invasive and much more efficient treatment. Finally, bio-hybrid 2 
implants rely on nanodevices able to cooperate not only with each others, but also 3 
with biological components (e.g., to restore the central nervous tracks or to sup-4 
port the immune system). 5 
As the design and manufacturing of devices at the nanoscale advance, new pos-6 
sibilities are given for the interconnection among nanodevices and new challenges 7 
rise in the development of protocols and channel models for nanonetworks. Based 8 
on the different types of nanodevices (i.e., biological, and electromagnetic), 9 
nanonetworks are mainly classified as (i) molecular [10], and (ii) electromagnetic 10 
[3].  11 
In this chapter, we investigate electromagnetic (EM) nanonetworks properties 12 
with different nanoparticles, working in the THz band, used for sensing and drug 13 
delivery, and foreseeing the transmission and reception of electromagnetic radia-14 
tion from components based on nanomaterials. In [3], Akyildiz and Jornet present 15 
the architecture of a nanosensor device as comprised of nanosensors, nanoactua-16 
tor, nano-memory, nano-antenna, nano-EM transceiver, nano-processor and nano-17 
power unit. All these components allow the integrated device to sense, compute or 18 
even perform local actuation. Furthermore, the authors foresee that nanosensor 19 
devices will potentially communicate among them in the terahertz band (i.e., 0.1-20 
10.0 THz).  21 
The main challenges of electromagnetic-based nanonetworks are expressed in 22 
terms of THz channel modeling, information encoding and protocols for nanosen-23 
sor networks. A physical channel model for wireless communication in the THz 24 
band has been developed by Jornet and Akyildiz in [11]. The presented model 25 
computes the signal path loss, the molecular absorption noise and, ultimately, the 26 
channel capacity of EM nanonetworks. In [12], a modulation and channel sharing 27 
mechanism based on the asynchronous exchange of femtosecond-long pulses 28 
transmitted through an on-off keying modulation is proposed for the transmission 29 
of binary streams among nanodevices of an EM nanonetwork. A medium access 30 
control protocol for EM nanonetworks built on the top of the pulse-based commu-31 
nication scheme in [12] for the coordination of multiple simultaneous transmis-32 
sions is presented in [13]. The proposed protocol is tailored to the peculiarities of 33 
the terahertz band and is constituted by two main stages i.e., (i) the handshaking 34 
process, and (ii) the transmission process. Finally, in [14] Jornet and Akyildiz 35 
have developed an energy model for self-powered nanosensor motes, which suc-36 
cessfully captures the correlation between the energy harvesting and the energy 37 
consumption processes. The energy harvesting process is realized by means of a 38 
piezoelectric nanogenerator, for which a new circuital model is developed that can 39 
accurately reproduce existing experimental data. The energy consumption process 40 
is due to the communication among nanosensor motes in the THz band. 41 
The application of nanoparticles for combined targeting and delivery of diag-42 
nostic and therapeutic agents has received significant attention in the last years 43 
[15]. Colloidal metallic nanoparticles have been recently investigated in the field 44 
4  
of nanomedicine, especially for drug delivery systems [16]. Noble metals, like sil-1 
ver and gold, are largely used for the design of nanoparticles, in the field of sens-2 
ing applications, as well as acting as carriers of medicament molecules. Particular-3 
ly, colloidal silver has been used as an antibacterial agent by weakening DNA 4 
replication and inactivating proteins, while gold has low toxicity to biological sys-5 
tems, and so results inefficient for antibiotic therapy [17]. In addition, nanoparti-6 
cles are also engineered to provide sustained drug release [18] [19], especially 7 
beneficial for chronic therapies. In [20], the authors use gold nanoparticles for di-8 
agnostic and drug delivery applications by exploiting chitosan. The use of chitosan 9 
serves dual purpose by acting as a reducing agent in the synthesis of gold nanopar-10 
ticles, and also promotes the penetration and uptake of peptide hormone insulin 11 
across the mucosa. As a first step towards real implementable solutions, in [21] 12 
nanomachines have been designed for medical applications to colonize and auton-13 
omously work inside the human body.  14 
Models for particulate DDS, based on the injection of drug molecules, have 15 
been proposed in [22, 23]. In [22], the authors consider the human blood vessels to 16 
model the medium where molecules diffuse, subjected to the cardiac input. Drug 17 
molecules are then allowed to move in every location of the cardiovascular sys-18 
tem. On the other side, the possibility of using a swarm of bio-nanomachines (i.e., 19 
nanoscale devices composed of natural or synthetic biological materials) with col-20 
lective behaviour, in order to perform collaborative tasks like target detection and 21 
molecule guiding, has been investigated by Nakano et al. in [23]. The same con-22 
cept of swarm of nanomachines has been utilized in [24], where endogenous dis-23 
eases of the brain are treated by means of nanodevices that communicate through 24 
acoustic signals. Finally, a multi-source nanonetwork model for extra-vivo bio-25 
medical diagnosis applications, specifically the detection of DNA alterations, is 26 
presented in [25].  27 
In this chapter we focus on the use of electromagnetic nanodevices for biomed-28 
ical applications, specifically sensing of DNA alterations and drug delivery 29 
through oral ingestion. After describing the main features of electromagnetic na-30 
noparticles used in biomedical applications, we consider a physical end-to-end 31 
model, and investigate how nanoparticles are transmitted, diffuse, and finally are 32 
captured. Furthermore, we also present simulation results that show the capability 33 
of nanosensors to operate in biomedical applications. 34 
This book chapter is organized as follows. In Section 2, we present different 35 
types of electromagnetic nanodevices (i.e., nanoparticles), and describe their spe-36 
cific features and properties. All these nanoparticles represent simple nanonodes, 37 
comprising an electromagnetic nanonetwork, and are then subjected to specific 38 
processes (i.e., transmission, diffusion, and reception). These are then investigated 39 
in Section 3. The sensing and drug delivery applications of nanoparticles are final-40 
ly presented in Section 4; we show specific use cases, by means of simulation re-41 
sults. Finally, conclusions and considerations on future investigations are drawn at 42 
the end of the chapter. 43 
5 
Electromagnetic nanoparticles for biomedical applications 1 
In the last few years the fabrication of nanostructures received too much atten-2 
tion. Optical properties of metallic nanoparticles make them suitable for biomedi-3 
cal applications [26]. In particular, gold nanoparticles have inner electromagnetic 4 
properties, depending on the size, shape, geometrical parameters, and the sur-5 
rounding dielectric environment Refractive Index (i.e., RI). To be more precise, 6 
the strongly enhanced Localized Surface Plasmon Resonance (LSPR) of this met-7 
al, at optical frequencies, makes it good light scatters and absorbers [27]. In addi-8 
tion to this, gold nanoparticles offer good bio-compatibility, optimal synthesis and 9 
conjugation properties [28], and are useful tools as contrast agents in cellular and 10 
biological imaging [29].  11 
Nanoparticles are of great interest in biomedical applications such as light scat-12 
tering microscopy-based imaging, sensing applications, and photothermal therapy 13 
for superficial and deep tumors treatment [30]. New sensing techniques to reveal 14 
malignant tissues are needed. For many optical sensors, proposed in literature, the 15 
presence of the biological sample is detected by measuring its refractive index in 16 
several ways [31].  17 
One of the most used techniques for biosensing is based on the LSPR phenom-18 
enon [32], which occurs when an electromagnetic plane wave impinges on metal-19 
lic nanoparticles that are electrically small. In this condition the free electrons of 20 
the nanoparticle follow collectively the electromagnetic oscillations. This phe-21 
nomenon derives from the peculiar metallic nanoparticles optical properties, and 22 
leads to a strong local electromagnetic field enhancement. Therefore, the resonant 23 
frequency of the electron motion strongly depends on the nanoparticle size, shape, 24 
composition, and surrounding dielectric environment [33]. 25 
In order to explain the nanoparticle electromagnetic properties, in terms of scat-26 
tering and absorption cross-section, the following assumptions need to be estab-27 
lished: 28 
• The particle size is much smaller than the wavelength in the surrounding medi-29 
um. In this case, under the limit of electrically small particles, the electromag-30 
netic field is approximately constant over the particle volume, and then the res-31 
onant behavior of the structure can be studied in terms of a quasi-static 32 
approximation; 33 
• The considered particle is homogeneous and isotropic. In addition, the sur-34 
rounding material is a homogeneous, isotropic and non-absorbing medium. 35 
Under previous assumptions, it is possible to relate the geometrical properties 36 
of the structure to its electromagnetic ones (i.e., scattering and absorption), by de-37 
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where V is the nanoparticle volume, 𝜀! is the dielectric permittivity of the sur-6 
rounding environment, 𝜀! is the complex dielectric permittivity of the metallic na-7 
noparticle, 𝑢! are unit vectors in the direction of the principal axes of the nanopar-8 
ticle, and 𝐿! (with n = [1, 2, 3]) are the three components of the corresponding 9 
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The depolarization dyadic L is an essential concept in the evaluation of the 12 
electric field in the source region, in order to establish the electromagnetic re-13 
sponse of an arbitrary shape of nanoparticle through the polarizability expression. 14 
From a physical point of view, it is a dimensionless matrix that allows taking into 15 
account anisotropic nanoparticles. 16 
Following the same procedure in [34], it is possible to develop new depolariza-17 
tion factors for specific nanoparticles, and then new analytical closed-form formu-18 
las for scattering and absorption cross-section can be derived. 19 
The general expression describing the extinction cross-section properties for 20 
different nanoparticles shapes can be written as the sum of absorption and scatter-21 
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where 𝑘 = !!"
!
 is the wavenumber, 𝜆 is the wavelength, and 𝑛 = 𝜀! is the refrac-24 
tive index of the surrounding dielectric environment. The extinction cross-section 25 
represents the effective area that governs the probability of scattering and absorp-26 
tion event by a nanoparticle. In general, the extinction cross-section is different 27 
from the geometrical cross-section of a particle, and it depends upon the wave-28 
length of light and the permittivity, shape and size of the particle. In terms of area, 29 
7 
the extinction cross-section [nm2] is the sum of the cross-sections due to absorp-1 
tion and scattering. 2 
Following this way, it is possible to predict in accurate manner the electromag-3 
netic response of each nanoparticle shape. This aspect is crucial in project phase, 4 
and allows optimizing the nanoparticles sensibility for specific applications.  5 
As shown in [35], considering cube, rod and elliptical cylinder nanoparticles, 6 
for each of the considered structures the analytical models have been calculated. 7 
By assuming that the structures are excited by a plane wave, having the electric 8 
field E and the vector propagation k directed as depicted in Figure 1, the polariza-9 















































































































,  (6) 13 
where E [ ] is the complete Elliptic Integral of the second kind, l [nm] is the cube 14 
side length, as well as the height of the nanorod and of the elliptical cylinder, d 15 
[nm] and c [nm] are the elliptical cylinder base axes lengths, t [nm] is the rod 16 
thickness, as well as the length of elliptical cylinder.  17 
Replacing (4), (5) and (6) in (1), and later in (3), the extinction cross-section 18 
spectrum for cube, rod and elliptical cylinder nanoparticles can be obtained [35]. 19 
In this way it is possible to predict the optimal geometrical parameters, in order to 20 
optimize the nanostructure for specific applications (i.e., biosensing applications). 21 
For example, in [36], a sensor revealing tumor and adipose tissue is presented. It 22 
consists of a gold linear chain of four nanocubes deposited on a silica substrate, 23 
and allows revealing the rat mammary cancer and adipose tissue by LSPR shift, as 24 






Figure 2. Extinction Cross-Section spectra for rat mammary cancer (RI = 1.39), and adipose tis-2 
sue (RI = 1.467), [36]. RI values are known in literature. 3 
 4 
By using very small inter-particle distance among the nanoparticles it is possi-5 
ble to obtain high-scattering and low-absorption efficiencies. These properties are 6 
very important for biosensing applications. In fact, high-absorption efficiency 7 
could heat the biological sample invalidating medical diagnosis. The biological 8 
sample used to test this device is an in-silico replica with values of RI taken from 9 
the literature. In particular the RI values of rat mammary adipose and tumor tissue 10 
have been considered. 11 
Finally, by using the same physical principle, in [37], a label-free immunosen-12 
sor was designed and fabricated for sensitive of alpha-fetoprotein (AFP) of gold 13 
nanorods. 14 
In literature various shapes of metallic nanoparticles are used for biosensing 15 
applications. For example, in [38] the ellipsoidal gold nanoparticles have been an-16 
alyzed, and a new analytical study of metallic nanoparticles working in the infra-17 
red and visible frequency range has been presented. The approach proposed in 18 
[38] is a useful tool to design nanostructures for sensing applications. 19 
Recently, another important property of metallic nanoparticles has been ana-20 
lyzed and exploited. In [39], an analytical and numerical investigation for modi-21 
fied gold nanorods, operating in the visible and in the infrared regime, is proposed. 22 
The modified particle consists in a core/shell structure (i.e., silica core, and gold 23 
shell) embedded in a dielectric environment, as shown in Figure 3. In order to 24 
study and to tune the electromagnetic nanostructure, a new analytical model has 25 
been developed. The electric field distribution at the resonant wavelength demon-26 
strates the intensity of the electromagnetic field in the neighborhood nanoparticle, 27 
as shown in Figure 4. This result derives from the silica core that allows the field 28 
intensification.  29 
Exploiting the obtained model, the nanoparticle sensitivity was studied and ver-30 
ified by full-wave simulations. In particular, being an asymmetric structure, the 31 
electromagnetic properties, in terms of extinction cross section (i.e., absorption 32 




Figure 3. Core/shell nanorod particles, and two mode excitations. 2 
 3 
       4 
Figure 4. Near electric field distribution at the resonant wavelength (i.e., 696 nm) of nanorod. 5 
 6 
As explained in [39], the difference between the longitudinal and transverse 7 
sensitivity can be explained in the following manner: it is known that nanoshells 8 
possess two resonances arising from the interaction between the classical plasmon 9 
resonance of the solid particle, and the resonance of the dielectric core inside the 10 
metal. The particle plasmon resonance holds increased sensitivity to the dielectric 11 
environment variation, especially for the longitudinal polarization. Instead, the di-12 
electric cavity resonance is much more sensitive to changes in dielectric properties 13 
within the nanoparticle core and shell dimensions for transverse polarization.  14 
Modified nanorods represent useful tools for sensing, since they combine two 15 
main optical properties of both nanorods (i.e., the high Aspect Ratio), and 16 
nanoshells (i.e., core/shell thickness), in order to reach the higher sensitivity. 17 
Thus, it allows additional degrees of freedom for the optical tenability of such par-18 
ticles. 19 
In the last few years several research have focused the attention to metallic na-20 
noparticles in a coupled configuration. In fact, to arrange gold nanoparticles in this 21 
way allows obtaining a greater intensification of the electromagnetic field, with 22 
respect to the single-element configuration. This aspect provides a nanostructure 23 
with major sensitivity in terms of LSPR shift [40]. Because the resonance of this 24 
coupled mode is sensitive to the gap distance change in the order of few tens of 25 
nanometers or less, it is inversely possible to measure such distances by monitor-26 
ing the scattering of the particle pair, the so-called plasmon ruler, as well de-27 
scribed in [40]. 28 
10  
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(a)             (b) 2 
Figure 5. Geometrical sketch of the bow-tie nanoparticle. (a) Top view of classical bow-tie parti-3 
cle, and (b) perspective view of modified bow-tie nanoparticle by dielectric incision. Geometrical 4 
parameters: a = 80 nm, b = 10 nm, c = 160 nm, d = 155 nm, e = 20 nm θ = 30°, and t = 25 nm. 5 
 6 
 7 
    (a)     (b) 8 
Figure 6. Extinction cross-section spectra for modified gold bow-tie nanoparticles, in the case of 9 
(a) analytical-numerical model comparison (normalized values) [41], and (b) local RI variation, 10 
inside the teal blue area. 11 
 12 
Another property of metallic nanoparticles consists of multi-resonant approach. 13 
In [41], a multi-resonant bow-tie structure is presented. The classical bow-tie na-14 
noparticle consists of two opposing truncated gold prisms, as depicted in Figure 5 15 
(a). In the classical bow-tie particle, the reason for the employment of the dielec-16 
tric hole, as shown in Figure 5 (b), is the possibility to excite a new resonant fre-17 
quency on the same structure in order to achieve a multi-band behavior. 18 
In this configuration the particles exhibit an additional resonant frequency, as 19 
reported in the following Figure 6. In order to tune and control the physical phe-20 
nomenon, and to design it with specific requirements, in [41] the analytical model 21 
has been developed. A good agreement among numerical and analytical results 22 
was achieved, as shown in Figure 6 (a). We notice that the nanostructures have 23 
been analyzed in terms of sensitivity properties, and results reveal that the modi-24 
fied bow-tie structure can be applied for biomedical applications. 25 
For example, it is well known that in the VIS-NIR tissues have a specific RI 26 
value, representing a unique physical property. Local RI changes in the tissue are 27 
related to different pathological conditions. In disease states, such as neoplasm or 28 
inflammation, color of tissue changes due to the change in RI, which in turn is re-29 
11 
lated to the relative permittivity of the tissue. Therefore, the dielectric constant 1 
changes as a result of different re-distributions in electron density of the tissue and 2 
it can be associated to different pathological conditions. 3 
The obtained results are shown in Figure 6 (b), where the local RI variation 4 
causes a selective shift in the extinction cross-section spectra (Peak II). In particu-5 
lar, Peak II associated to the local RI variation inside the teal blue area shifts from 6 
717 nm to 820 nm for 1 < RI < 1.6. The mean sensitivity value is 171 nm/RIU. 7 
Transmission, Diffusion and Reception process in 8 
Electromagnetic Nanonetworks 9 
After describing the main features of electromagnetic nanoparticles used in bi-10 
omedical applications, like sensing and drug delivery, in this section we investi-11 
gate how nanoparticles are transmitted, diffuse, and finally are captured in a phys-12 
ical end-to-end model.  13 
The concept of electromagnetic nanonetworks holds classical basics of both in-14 
formation theory, and electromagnetic propagation. The specific feature is the use 15 
of engineered metallic nanoparticles, working in the THz frequency range, which 16 
are exploited by means of the use of LSPR phenomenon.  17 
From the communication and channel modelling point of view, the electromag-18 
netic nanonetworks represent a nanonetwork where the nanonodes are metallic 19 
nanoparticles, as small as molecules, and then depending on diffusion-based nano-20 
communications. Following this consideration, we can compare a flow of nano-21 
particles as a flow of molecules, and the electromagnetic theory laws are applied 22 
for sensing applications, by exploiting the interaction of an impinging electromag-23 
netic wave with the metallic surface of the nanostructures.  24 
In a nanonetwork utilized for sensing or drug delivery purposes, from the point 25 
of view of the information theory, the transmitter is represented by the source 26 
(i.e., nanomachine) that emits nanoparticles, while the receiver is the set of target 27 
cells laying in the area where a phenomenon needs to be sensed or a drug needs to 28 
be delivered. Due to the particular nature of nanoparticles (i.e., very small devices 29 
at nanoscale level), the propagation process allows nanoparticles to move along 30 
the space linking the transmitter to the receiver, according to a diffusion model. 31 
Communications via Diffusions (CvD) arise from molecular nanonetworks [42, 32 
60], where specific molecules, called messenger molecules, act as the information 33 
carriers between two nanomachines residing in close-to-medium proximity to each 34 







Figure 7. End-to-end physical model of an electromagnetic nanonetwork for sensing or drug 2 
delivery purposes. The transmitter is represented by a nanomachine, filled with a nanoparticle 3 
concentration, exiting and diffusing into the medium (i.e., the space S). The nanoparticles act ei-4 
ther as drug carriers for drug delivery applications, or as bio-functionalized nanodevices for 5 
sensing applications. The receiver is often represented by a target site (e.g., a group of tumor 6 
cells), with receptors for capturing the nanoparticles. The sensing and drug delivery applications 7 
occur only when the nanoparticles have been bound to the receiver’s receptors. 8 
 9 
In our vision, CvD systems can be also applied to electromagnetic nanonet-10 
works, due to common features between molecules and metallic nanoparticles. In-11 
deed, a single nanoparticle is an indivisible object, like a molecule, which is re-12 
leased (during the emission process), or collected by means of chemical reactions 13 
(during the reception process). At the same time, a nanoparticle can act as mes-14 
senger nanoparticle, since it can carry information, such as drug concentration. 15 
Furthermore, metallic nanoparticles constituting the electromagnetic nanonetwork 16 
are passive nanodevices that is, they cannot transmit data information (e.g., drug 17 
molecules) by themselves, but need to be impinged by an electromagnetic wave in 18 
order to release information. Due to all these features, electromagnetic nanoparti-19 
cles are assumed to be very similar to molecules. 20 
Several works have thought of the transmitter as a nanomachine or a bio-21 
engineered cell capable of emitting nanoparticles and releasing them into the me-22 
dium to change their concentration [43]. Similarly, the receiver is capable of cap-23 
turing the nanoparticles, by using ligand-receptor bindings [44], [45].  24 
If a nanoparticle collides with a receiver, it means that the nanoparticle hits the 25 
receiver, and the nanoparticle is then removed from the system since the couple 26 
ligand-receptor at a receiver forms a chemical bond with the messenger nanoparti-27 
cle [46]. Indeed, it is assumed that the whole surface of the receiver is composed 28 
of receptors, which are able to bind with the messenger nanoparticles. It follows 29 
that each received nanoparticle constitutes the signal just once. This process is 30 
named first hitting process [67]. On the other side, if a nanoparticle hits a transmit-31 
ter, it bounces back from the transmitter since a transmitter does not have the same 32 
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The receiver is often a biological sample (i.e., a tumor tissue), and has a large 1 
number of binding places, so that it can estimate the concentration by averaging 2 
over all the created bonds.  3 
From all previous considerations, a nanonetwork can be represented by the fol-4 
lowing main processes [6, 42]: 5 
1. Emission: this process investigates how nanoparticles are transmitted 6 
from a nanomachine (or a set of nanomachines); 7 
2. Diffusion: illustrates how nanoparticles diffuse along the gap that sepa-8 
rates the transmitter from the receiver lying in the common space S; 9 
3. Reception: describes how nanoparticles are captured by the receiver, by 10 
means of ligand-receptor bindings. 11 
The transmitter releases a number of nanoparticles in a time slotted fashion. 12 
These messenger nanoparticles scatter in the medium following the probabilistic 13 
diffusion dynamics in the environment. Some of these released nanoparticles are 14 
received via receptors in the cell membrane. 15 
All the above-mentioned processes take place inside a space S, which is strictly 16 
related to the application for which the nanonetwork is designed, and it is initially 17 
filled with a homogeneous concentration of particles equal to zero. The physical 18 
end-to-end model is depicted through the scheme in Figure 7, where the main 19 
modules of emission, diffusion and reception of nanoparticles are represented. 20 
In the recent years, many studies have focused on the channel capacity and 21 
propagation dynamics of the CvD medium [46, 48, 49, 50]. Some of these propa-22 
gation process studies consider the probabilistic behaviour of the channel as the 23 
transfer function of the system, while others model it as a unique noise source in-24 
herent to a diffusion medium. According to the aforementioned studies on channel 25 
capacity, it has been shown that the reliability of the transmission diminishes ex-26 
ponentially with increasing transmission range, while the average end-to-end de-27 
lay increases exponentially. These results limit the effective communication range 28 
of the CvD systems to a few tens of micrometers. 29 
Several studies on CvD systems focus on a single transmitter single receiver 30 
systems. However, when there are more communicating couples in the environ-31 
ment, additional issues arise (i.e., interference and noise). An important issue is 32 
the interference between closely placed transmitting couples in the same medium. 33 
When two or more transmitting pairs try to communicate simultaneously using the 34 
same technique and the same type of messenger nanoparticles, their signals affect 35 
each other and reduce/increase the Signal-to-Noise and Interference Ratio (SINR) 36 
of all nearby transmissions.  37 
14  
Emission process 1 
The emission process aims to modulate the nanoparticle concentration rate (i.e., 2 
rT (t)) at the transmitter. This is the first process occurring in the end-to-end physi-3 
cal model, as depicted in Figure 7. 4 
In [49], Pierobon and Akyildiz developed a mathematical framework to inter-5 
pret the diffusion-based nanoparticle communications, in the simple case of one 6 
transmitter and one receiver. The emission process has been modelled by means of 7 
the electrical circuit theory, considering a RC circuit, where the capacitor charg-8 
ing/discharging current is related to the net flux of nanoparticles. Then, the parti-9 







.   (8) 11 
The approach in [49] represents the classical representation of nanoparticle 12 
emission in diffusion-based nanonetworks. Following this vision, the work in [50] 13 
is based on a pulse-based modulation scheme applied to diffusion-based commu-14 
nication nanonetworks. Whenever a transmitter (i.e., a nanomachine) wants to 15 
communicate some information to its neighbours, it instantaneously releases a 16 
pulse of nanoparticles (e.g., molecules). This creates a spike in the nanoparticle 17 
concentration at the transmitter location, which then propagates through space and 18 
time. Notice that the nanoparticle concentration does not only depend on time, but 19 
it also varies along the space. The propagation of this pulse can be analytically 20 
modelled by solving Fick’s Laws of Diffusion. 21 
If the transmitter releases Q molecules at the instant t = 0, the molecular con-22 
centration at any position x [nm] in space, from the transmitter location is given 23 
by: 24 
c x,t( ) = Q
4!Dt( )3/2
e! x
2 /4Dt ,   (9) 25 
where t [s] is the time, and D [cm2/s] is the diffusion coefficient, assumed as a 26 
constant value for a given fluidic medium, and depending on the size and shape of 27 
the nanoparticles, as well as the interaction with the solvent and viscosity of the 28 
solvent. Eq. (9) allows obtaining the concentration measured by a receiver located 29 
at a distance x = r [nm] from the transmitter as a function of time. We can observe 30 
that the concentration initially measured by the receiver is zero, but it sharply in-31 
creases until reaching its maximum. The time instant at which this maximum oc-32 
curs can be interpreted as the pulse delay. After the concentration peak is reached, 33 
the impulse response slowly decreases, forming a long tail due to the effect of dif-34 
fusion. In 1-D environments, it is easy to obtain the closed form solution for the 35 
15 
first hitting probability function, since the nanoparticles diffusing along the fluid 1 
hit the receiver with probability 1, thus representing a recurrent process. The ex-2 
pression of the first hitting probability Fh (r0, t) for a point source in 1-D environ-3 
ment is  4 
 




2 /4Dt ,   (10) 5 
where r0 [nm] is the distance to the receiver. On the other side, in 3-D environ-6 
ments solving the first hitting probability function is a hard surface integration or 7 
differential equation problem, since there is a nonzero probability for a diffusing 8 
nanoparticle to miss the receiver [66]. As a solution for the 3-D case, Yilmaz et al. 9 
[67] simulate the first hitting process following a Gaussian distribution for each 10 
movement at each dimension in one time step made by messenger molecules, i.e. 11 
!xi ! N 0,2D!t( ),   (11) 12 
where  !xi  [nm] is the displacement at the i-th dimension (with i = {1, 2, …, n}), 13 
 !t  [ns] is the time step, and assuming a reflection or removal of those particles 14 
that hit to transmitter or receiver, respectively. 15 
In some biomedical applications, like extra-vivo sensing, a multi-source nano-16 
particle emission process can be required. As an instance, target cell detecting can 17 
be tailored to the detection of DNA alterations of the BReast CAncer susceptibil-18 
ity gene 1 (BRCA1). As known, BRCA1 is a human gene belonging to a class of 19 
genes known as tumor suppressors. Mutation of these gene causes a genetic sus-20 
ceptibility to breast cancer, and changes in its alternative splicing profile have 21 
been associated with malignant transformations that greatly increase woman’s risk 22 
of developing breast cancer [51, 52].  23 
In this scenario, the emission process should be designed to allow the capture 24 
of target BRCA1 DNA sequences through a set of unit cells, each of them com-25 
posed of square gold patches (receptors) deposited on a silica substrate. Each re-26 
ceptor is functionalized with the structure of the BRCA1 splice with the corre-27 
sponding sandwich assays. The chemical receptors are BRCA1 alternative splice 28 
variants i.e., Δ(5q, 6), Δ(9, 10), and Δ(11q) [53]. Figure 8 (a) depicts the end-to-29 
end physical model for the detection of BRCA1 DNA alterations [25].  30 
In this case, each nanomachine can emit a particular type of nanoparticles (i.e., 31 
with a given shape and size), and the chemical receptors are accordingly function-32 
alized for the capture of one type of nanoparticle. Then, the transmitter (i.e., repre-33 
sented by the syringe) is comprised of three nanoparticles flows, injected all to-34 
gether in a sink with a biological tissue, and each constituted of different shapes 35 
nanoparticles (see Figure 8 (a)). The receiver is represented by the unit cell of a 36 




Figure 8. End-to-End physical model in (a) sensing (i.e., multiple-detection of DNA alterations) 1 
[25], and (b) drug delivery (i.e., stomach disease therapy) applications. 2 
 3 
A multi-source nanonetwork can suffer from synchronous and asynchronous 4 
transmissions, which can degrade network performance with an increase of inter-5 
ference. The same consideration exists at the receiver side, where a selective re-6 
ception of nanoparticles occurs. As expected, a nanoparticle (a)synchronous 7 
transmission corresponds to a (a)synchronous reception. In the case of asynchro-8 
nous emission, just one nanomachine has transmitted a flow of nanoparticles, and 9 
then just one kind of ligand-receptor bind can occur (e.g., the nanomachine 2 has 10 
transmitted a flow of nanocubes), while in the synchronous case, all the na-11 
nomachines have transmitted the own nanoparticles.  12 
In the case of synchronous emission, nanoparticles detection issues are limited 13 
and not likely to occur since each nanoparticle is allowed forming a ligand-14 
receptor binding with a given receptor. As a result, no ambiguity issue regarding 15 
the nanoparticle detection can occur. However, during the diffusion process, the 16 
flows of nanoparticles can be affected by interferences (i.e., other nanoparticles 17 
can be recognized as belonging to the same flow), and this provides a change in 18 
the emission rate of the single nanomachine. 19 
Finally, in oral drug delivery systems, the drug delivery process can occur via 20 
different modalities, such as oral ingestion, and injection.  21 
In [22], the diffusion of nanoparticles within the human body is modelled as a 22 
diffusion-based nanonetwork, under the specific features of the blood flow.  23 
In oral drug delivery, the recommended total dose of drug is delivered through 24 
the medicament concentration filled into a sachet, and encapsulated or compressed 25 










obtained by conjugating drug-encapsulated nanoparticles with targeting ligands, 1 
which could facilitate the preferential delivery of nanotherapeutics to the sites of 2 
interest, while reducing undesired side effects elsewhere. In this case, metallic na-3 
noparticles, filled with typical drugs for antitumoral therapy, and covered with a 4 
polymer that allows a higher resistance to the Gastro-Intestinal tract barrier, are 5 
used. In this particular scenario, the flow of nanoparticles is emitted by a tablet, as 6 
well depicted in Figure 8 (b).  7 
We assume that each nanoparticle is covered by a polymer that releases drugs, 8 
when induced by stimulation, able to cause a change in the nanostructure.  9 
In general, stimulus-responsive polymeric nanoparticles, namely smart nano-10 
particles, could undergo structure, shape, and property changes after being ex-11 
posed to external signals, such as pH, temperature, magnetic field, and light, large-12 
ly used to modulate the macroscopical behavior of the nanoparticles. Table 1 13 
collects the main smart polymers used for drug delivery systems.  14 
In the literature several works have focused on pH and temperature as the pre-15 
dominant stimulus signals, so that pH- and thermo-responsive nanoparticles have 16 
been extensively studied [71, 74, 75, 76]. As an instance, the most commonly used 17 
thermo- and pH-sensitive segments are poly(N-isopropy- lacrylamide) (PNIPP 18 
Am) and poly(acrylic acid) (PAA), respectively [76, 77, 78, 79]. 19 
 20 
Table 1. Examples of smart polymers used for drug delivery systems [68]. 21 
Stimulus Polymer Drug Released 
pH Poly(methacrylic-g-ethylene 
glicol) – p(MMA-g-EG) 
Insulin 




















anhydride maleic copolymer 
Hydrocortisone 
Diffusion process 22 
The characterization of the diffusion process derives from the capability to 23 
learn from biology and has mainly inspired molecular nanocommunication sys-24 
tems.  25 
18  
 1 
Figure 9. Schematic of diffusion process, where nanoparticles move from high to low concen-2 
tration levels. 3 
 4 
In Figure 9, we can see an example of how the diffusion process works. Inde-5 
pendently from the type of communication (i.e., molecular or electromagnetic), it 6 
is worth to discuss about the main physical principles of the fluid dynamics that 7 
are the milestones of the diffusion process. In fact, the main mechanism that 8 
drives the communication among nanoparticles is the free diffusion of nanoparti-9 
cles in the space.  10 
First of all it is useful to start from the beginning, the Fick’s First Law of Diffu-11 







x,t( ) = !D"c x,t( ) ,   (10) 14 
where 
 
!c x,t( )  represents the concentration gradient per unit length. It follows 15 
that JT (x, t) is the flow of solute, and then Eq. (10) can be identified with the na-16 
noparticle concentration flux at the output of the transmitter, dependent on the na-17 
noparticle concentration gradient at time t and position x. 18 
In practice, the Fick’s First Law of Diffusion describes the diffusion as the pro-19 
cess where a solute moves from a region of high concentration to a lower concen-20 
tration area. Usually, there is a predominant direction of the flow, from the highest 21 
to the smaller concentration region, but diffusion is a complex phenomenon and 22 
also occurs in the opposite direction. 23 
This more complex phenomenon can be described as a function of time by de-24 
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Some studies present the propagation of messenger nanoparticles by means of 1 
free diffusion. In [55], the authors discuss about two simple models of phero-2 
mones diffusion in still air that are different in terms of the emitting scheme. The 3 
first one treats instantaneous emission whereas the second considers the continu-4 
ous emission of pheromones. Communications via Diffusion (CvD) in a fluid are 5 
investigated in [56], where the authors show how the most of the studies about 6 
CvD systems is based on a very simple assumption, namely the systems are with a 7 
single transmitter and a single receiver. They analyzed a more realistic situation, 8 
that is, there are more communicating couples that make the systems much more 9 
complicated. In fact, the authors focus on the interference between closely located 10 
transmitting couples that share the same medium.  11 
In [21] authors consider the diffusion process from a very interesting perspec-12 
tive, and for a very important application i.e., the development of nanorobots with 13 
sensors for nanomedicine. They show how, for an intra-body application, it is pos-14 
sible to apply fluid dynamics rules, by describing the fluid through the classical 15 
continuum equations. By applying the Navier-Stokes equation and the continuity 16 
condition, they are able to derive the velocity of the fluid. In their work they con-17 
sider two types of forces the nanoparticles are subjected to, namely deterministic 18 
forces, due to the fluid motion, and stochastic forces due to thermal motion of na-19 
noparticles in the fluid. Stochastic forces give rise to additional random motion, 20 
i.e., Brownian motion. The different perspective of the diffusion as considered by 21 
Cavalcanti et al. consists on the fact that a nanorobot is considered at rest with re-22 
spect to the rest to the fluid, but it will be able to collect biomolecules (that is the 23 
main task of the nanorobot), due to the diffusion of the biomolecules. 24 
Based on the main concept and the same principles of the CvD, authors in [25] 25 
show how the diffusion process works in the case of electromagnetic nanoparti-26 
cles. More specifically, the authors show that gold nanoparticles can behave simi-27 
larly to the molecules. In particular, different geometries are assumed, but the dif-28 
ferent nanomachines are similar in terms of volume occupancy. This characteristic 29 
simplifies the analysis of the diffusion process, even if the authors consider a 30 
three-dimensional space i.e., a lattice, to describe the diffusion phenomenon. 31 
Reception process 32 
In sensing applications designed for the detection of chemical and biological 33 
agents, nanoparticles (specifically, nanosensors) are usually composed of (i) a 34 
recognition system or receptor, and (ii) a transduction mechanism.  35 
Nanosensors can be based on the use of noble metal nanoparticles [57] (e.g., 36 
gold nanoparticles) and are functionalized with a biological receptor, such as an 37 
antibody, that is bound to the specific antigen of a given disease. The ligand-38 
receptor binding [58] is, therefore, the mechanism that starts the reception process. 39 
20  
In several works [47, 59], a particle receiver model is developed by taking the lig-1 
and-receptor binding mechanism into account. 2 
The binding event between the recognition element and the target can alter 3 
physicochemical properties of the transducer that, in turn, can generate a detecta-4 
ble response signal. In particular, the binding creation changes the resonant fre-5 
quency of the surface plasmons resulting from light irradiation. Through the LSPR 6 
technique, it is then possible to perform chemical or biological sensing. 7 
The two main operations (i.e., binding creation, and signalling transduction) 8 
that occur in the reception process are depicted in Figure 10, for the case of sens-9 
ing application through metallic nanoparticles. 10 
From the above considerations, it follows that the reception process has the task 11 
of (i) sensing the particle concentration at the receiver, and (ii) producing, accord-12 
ingly, the output signal. As an example of sensing application, in the case of de-13 
tection of BRCA1 DNA alterations [25], receptors take place only in correspond-14 
ence of BRCA1 alternative splice variants, i.e., Δ(5q, 6), Δ(9, 10), and Δ(11q) 15 
[53].  16 
The binding reaction occurs when the receptor was not previously bound to a 17 
particle. A chemical receptor, depending whether it is involved in a complex or 18 
not, triggers an output signal accordingly. The output signal of the end-to-end 19 
model results proportional to the rate of change in the ratio τ of the number of 20 
bound chemical receptors over the total number of chemical receptors. The trend 21 
is to reach a ratio between the number of bound chemical receptors over the total 22 
number of chemical receptors. The variation of the number of bound chemical re-23 
ceptors nc (t) inside the reception space at time t is related to the number of recep-24 










.   (13) 26 
According to the ligand-receptor binding reaction kinetic, when a set of nano-27 
particles (i.e., NP), accordingly functionalized with a given antigen, are emitted by 28 
the transmitter nanomachine, encounters with receptors (i.e., R) lying on the re-29 
ceiver, nanoparticles bind the receptors. These bound nanoparticle-receptors (i.e., 30 
NP+R) constitute complexes (i.e., bound receptors), as well as it is possible to re-31 
lease molecules NP from receptors R, respectively according to the following 32 
chemical reactions [47], 33 
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 1 
Figure 10. Schematization of the reception process in electromagnetic nanonetworks. 2 
 3 
where k1 [μmol/L/s] and k−1 [s –1] is the rate of binding reaction, and the rate of re-4 
lease reaction, respectively. 5 
In the case of drug delivery systems that make use of hollow metallic nanopar-6 
ticles opportunely filled with drug concentration to be released locally, as the oral 7 
administration of a tablet for stomach disease therapy, depicted in Figure 8 (b), the 8 
further step of drug release needs to be accomplished.  9 
The breakage of the polymer that covers the nanoparticle is also realized by 10 
means of an electromagnetic impinging plane wave that causes the polymer chains 11 
to collapse, exposing the holes on the metallic nanoparticle, and thereby releasing 12 
the pre-loaded effector. 13 
In [69] it was shown that for temperature increase, the core layer of PNIPAAm 14 
packed more compactly, then causing the decrease in the nanoparticle size. The 15 
drug release test showed the drug release was rapid at low pH medium from drug-16 
loading nanoparticle. Indeed, it is known that under a temperature stimulus, the 17 
LSPR phenomenon is established, and the free electrons of the nanoparticles fol-18 
low collectively the electromagnetic oscillations. As a result, the absorbed incident 19 
electromagnetic field at the resonant wavelength is converted into heat through the 20 
photothermal effect [70]. The increase of temperature causes the polymer chains 21 
to collapse, thus exposing the holes on the nanoparticle, and thereby releasing the 22 
drug concentration. Therefore, the drug is released at the appropriate time and 23 
place.  24 
Also, Li et al. synthesized a Y-shaped pH-/thermo-responsive copolymer 25 
P(UA-Y-NIPAAm) composed of pH sensitive poly(undecylenic acid) (PUA) 26 
segment and temperature-sensitive poly(N- isopropylacrylamide) (PNIPAAm) 27 
segment [72]. Soppimath et al. prepared novel temperature responsive nanoparti-28 
cles with the transition at physiological temperature [73], whose structure could be 29 
deformed in acid environments to induce the release of encapsulated drug.  30 
To summarize, the drug release mechanism based on polymers aims to [68]:  31 
• improve the pharmaceutical profile and stability of a drug,  32 
• ensure its correct concentration,  33 
• achieve maximum biocompatibility,  34 
• minimize side effects,  35 
• stabilize the drug in vivo and in vitro,  36 
• facilitate the accumulation of the drug at a specific site of action,  37 
22  
• increase exposure time in the target cell. 1 
 2 
The above-mentioned nanoscale sensing technologies require the use of exter-3 
nal excitation and measurement equipment to operate. In the vision of future na-4 
nosensors devices [3] equipped with nanosensors, nanoactuator, nano-memory, 5 
nano-antenna, nano-EM transceiver, nano-processor and nano-power unit, 6 
nanodevices will be able to exchange information through nano-electromagnetic 7 
communications. By means of communication, the nanomachines will be able to 8 
accomplish more complex missions in a cooperative manner. As an example, na-9 
nosensors will be able to transmit the sensed information in a multi-hop fashion to 10 
a sink or a command centre.  11 
For electromagnetic nanonetworks, the use of modulation and channel sharing 12 
mechanism based on the asynchronous exchange of femtosecond-long pulses, 13 
which are transmitted following an on-off keying modulation spread in time, has 14 
been proposed [12]. In [61], a receiver architecture for electromagnetic nanonet-15 
works that make use of pulse-based modulation has been proposed. The receiver is 16 
designed in order to be simple and robust, and it is based on a Continuous-Time 17 
Moving Average (CTMA) symbol detection scheme. This scheme bases its deci-18 
sion in the received signal power maximum peak after the CTMA, which is im-19 
plemented with a single low-pass filter. Afterwards, to decode the symbol, this 20 
maximum is compared with a previously defined threshold. 21 
Nanoparticulate Sensing and Drug Delivery 22 
Recently, by functionalizing the nanoparticles with biological agents such as 23 
antibodies or single stranded DNA chains, nanoparticles are forced to bind prefer-24 
ably to specific target cells. This aspect is the focus of extra-vivo sensing applica-25 
tion, such as the multi-detection of DNA alterations of the BRCA1. 26 
Several works addressing the issue of DNA detection exploit metallic nanopar-27 
ticles, in order to enhance the Raman signal of fluorescent target absorbed on the 28 
metallic surface. The predominant mechanism responsible for this enhancement 29 
arises from the local electromagnetic field intensification at the surface of noble 30 
metal nanoparticles. This method is called Surface-Enhanced Raman Scattering 31 
(SERS), [80]. Among main SERS-based studies, the majority uses fluorophores as 32 
Raman labels, but it has been shown that they reduces the Raman scattering effi-33 
ciency, due to the displacement of fluorophores by biological media [80].  34 
On the other hand, techniques based on the use of metallic nanoparticles illu-35 
minated by an electromagnetic wave (visible and near infrared region) are largely 36 
exploited, as alternative approaches for gene alterations detection [62, 63]. More 37 
specifically in [25], the LSPR phenomenon for the multi-detection of BRCA1 38 
DNA alteration, when biological gold nanoparticles are captured at the receiver, 39 
has been presented.  40 
23 
 1 
Figure 11. Ligand-receptor binding of three nanoparticles. Green, black and violet sections 2 
represent the Target Sequences for each nanoparticle [25]. 3 
 4 
In this approach, it is crucial to obtain different and independent electromagnet-5 
ic responses from each nanoparticle in terms of resonant wavelength, amplitude 6 
and magnitude width. Cube, rod and elliptical cylinder nanoparticles have been 7 
functionalized with the corresponding probe sequences of alternative splicing 8 
junctions of BRCA1, as shown in Figure 11. The three corresponding DNA cap-9 
ture sequences of alternative splicing junctions of BRCA1 are allocated on three 10 
square gold patches of silica substrate, as depicted in Figure 11. 11 
Furthermore, Figure 11 shows the unit cell of the sensing platform, composed 12 
of three square gold patches, functionalized with three different Capture Sequenc-13 
es (specifically, depicted in blue, red and green). The sensing platform is excited 14 
by an impinging plane wave, the excitation is employed to analyze the electro-15 
magnetic properties, in terms of extinction cross-section spectra, as reported in 16 
Figure 12 for the case of cube, rod, and elliptical cylinder nanoparticles, in binding 17 
and no-binding. 18 
The meaning of this result is the lack of overlapping of the extinction cross-19 
section spectra generated by the nanoparticles. In other words, it is crucial that the 20 
resonant peaks do not overlap, in order to obtain a multi-sensing approach. This 21 
result has been reached by using the aforementioned analytical model; in fact, they 22 
have allowed tuning the electromagnetic response for each nanoparticle. In addi-23 
tion to this, two cases of nanoparticle detection have been considered: the asyn-24 
chronous and synchronous. In the first case, just one nanomachine has transmitted 25 
a flow of nanoparticles, and so we have just one kind of ligand-receptor bind, 26 
while in the synchronous case, all the nanomachines have transmitted the own na-27 
noparticles, as shown in Figure 12. In this way, it is still possible to detect the 28 
DNA alteration as in the asynchronous case. The synchronous case is very im-29 
portant for multi-detection, since it allows the detection of different DNA altera-30 
tions. 31 
To demonstrate this ability, the extinction cross-section spectra for cube, rod 32 
and elliptical cylinder binding in the asynchronous case are shown in Figure 13 33 
(a), (b), and (c), respectively. Figure 13 shows the capability of the nanosensors to 34 
distinguish the different BRCA1 alterations. Furthermore, these results prove the 35 
structure capability to be able to reveal BRCA1 alterations in the case of double 36 
binding e.g. (i) nanocube, and nanorod particle binding, (ii) nanocube and ellipti-37 
cal cylinder binding, and (iii) nanorod and elliptical cylinder binding. 38 
24  
 1 
Figure 12. Synchronous nanoparticle detection [25]. Extinction Cross-Section spectra ob-2 




(a)    (b)             (c) 7 
Figure 13. Asynchronous detection [25]. Extinction Cross-Section spectra obtained for binding of 8 
(a) nanocube, (b) nanorod, and (c) elliptical cylinder nanoparticle.  9 
 10 
In the last few years several researches have focused the attention on the drug 11 
release by using functionalized gold nanoparticles [64]. The goal of this technique 12 
is to use specifics nanoparticles as drug carriers. Among the different used ap-13 
proaches, the photothermal effect appears as a great promise in the drug delivery 14 
field. When a metallic nanoparticle is illuminated by electromagnetic field in the 15 
visible and near infrared frequencies regime, the LSPR-induced local heating 16 
causes the release of loaded drug; this leads to enhanced drug efficacy with high 17 
spatio-temporal resolution, and very few side effects. In fact, the high electric field 18 
concentration on the nanoparticles surface ensures the heat of particle and, there-19 
fore, it causes the polymer chains to collapse, exposing the holes on the nanoparti-20 
cles and thereby releasing the pre-loaded effector. 21 
The same principle used in [25] could be efficiently applied to in-vivo drug de-22 
livery system. More specifically, it is possible to use different shapes of nanoparti-23 
cles to release more types of drug. As shown in [65], there are cases that need of a 24 
multiple drug release in different times. Selective releases were induced by selec-25 
tive hot-spots of gold nanorods by electromagnetic field irradiation at the reso-26 
nance frequency of the nanorod. In this way, at specific wavelengths it is possible 27 
to excite one type of gold nanorods, and selectively release one type of DNA 28 
strand [65]. 29 
25 
By using the aforementioned nanoparticles, it is possible to load different drugs 1 
into distinct different nanoparticles shapes and by tuning the electromagnetic field 2 
frequency will be possible to excite specific nanoparticles. Therefore, by exploit-3 
ing the photothermal effect, only selective drugs will be released, in the case of 4 
drug delivery applications and only selective DNA chains will be detected, in the 5 
case of sensitive applications. As results, the use of different nanoparticles shapes 6 
enables independent control over the release of each drug by tuning the nanoparti-7 
cles, leading to a programmed release of multiple drugs. 8 
Finally, another work dealing on the use of nanoparticles for sensing applica-9 
tions (i.e., detection of DNA alterations) is given in [81]. Specifically, two-layers 10 
nanostructures are considered, comprising of a SiO2 core, and a gold shell with 11 
different thicknesses. By varying the ratio of the core/shell radius, it is possible to 12 
tune the electromagnetic response. Indeed, the optical cross-section propriety ob-13 
tained for nanoshells with different radii is higher than that one obtained for the 14 
nanoshells with the same volumes. 15 
Simulation results in [81] show the extinction cross-section spectra in the case 16 
of (i) synchronous nanoparticle transmission, (ii) asynchronous nanoparticle 17 
transmission, and (iii) no nanoparticle reception. The extinction cross-section 18 
spectra show a peak at 550 nm for both synchronous and asynchronous transmis-19 
sion, but the magnitude of the spectral signal is higher for the synchronous trans-20 
mission, with respect to the asynchronous case. In both two cases, no shift of the 21 
resonant wavelength occurs. From a physical point of view, this means that there 22 
are no coupling effects among nanoparticles. Finally, as expected, in the case of 23 
no nanoparticle reception, the extinction cross-section spectrum is approximately 24 
zero. 25 
Conclusions  26 
In this chapter we have addressed recent advances in electromagnetic nanonet-27 
works for biomedical applications. Starting from the description of most used na-28 
noparticles for sensing and drug delivery systems (i.e., nanorods, nanocubes, bow-29 
tie nanoparticles, etc.), we have presented the analytical models behind their spe-30 
cific properties. By exploiting the well-known LSPR phenomenon, electromagnet-31 
ic nanoparticles are shown to be very suitable for sensing (i.e., analysis of concen-32 
tration of specific substances), and drug delivery applications (i.e., nanoparticles 33 
are intended as drug carriers for localized drug release).  34 
Furthermore, under the assumption of similarity of electromagnetic nanoparti-35 
cles with biological molecules (i.e., small size of the structure), we rely on specific 36 
laws in the nanoscale. The channel model linking one transmitter to one receiver is 37 
generally represented by a liquid environment (i.e., the human blood flood or the 38 
biological tissue), and is subjected to specific processes (i.e., nanoparticle trans-39 
26  
mission, diffusion, and reception). Once nanoparticles are captured by the recep-1 
tors, the detection process occurs by means of LSPR phenomenon.  2 
Specific sensing and drug delivery applications of nanoparticles are also pre-3 
sented, regarding the detection of DNA alterations of BRCA1 gene, as well as for 4 
fighting stomach diseases. The case of different shapes of nanoparticles has been 5 
addressed, both for sensing and drug delivery applications, by showing how dif-6 
ferent geometric forms can be exploited for multi-detection sensing and to effec-7 
tively regulate programmed drug delivery, respectively.  8 
Simulation results assess the validity of the use of electromagnetic nanoparti-9 
cles for these biomedical applications.  10 
As a future investigation, novel nanomaterials are promising for the design of 11 
innovative nanodevices. As an instance, graphene-based nanoantennas can provide 12 
outstanding sensing capabilities, as well as graphene-based transistors are not only 13 
smaller, but predictably faster too. 14 
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